<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01363440</url>
  </required_header>
  <id_info>
    <org_study_id>VGFT-OD-1009</org_study_id>
    <nct_id>NCT01363440</nct_id>
  </id_info>
  <brief_title>Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema</brief_title>
  <acronym>VISTA DME</acronym>
  <official_title>A Double-Masked, Randomized, Active-Controlled, Phase 3 Study of the Efficacy and Safety of Intravitreal Administration of VEGF Trap-Eye in Patients With Diabetic Macular Edema</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Regeneron Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Regeneron Pharmaceuticals</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the efficacy of Intravitreal Aflibercept Injection
      (IAI; EYLEA®; BAY86-5321) on the best corrected visual acuity (BCVA) assessed by the early
      treatment diabetic retinopathy study (ETDRS) chart in patients with diabetic macular edema
      (DME) with central involvement.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in Best Corrected Visual Acuity (BCVA) as Measured by Early Treatment Diabetic Retinopathy Study (ETDRS) Letter Score at Week 52 - Last Observation Carried Forward (LOCF)</measure>
    <time_frame>Baseline and Week 52</time_frame>
    <description>Visual function of the study eye was assessed using the ETDRS protocol. Participants with a BCVA ETDRS letter score of 73 to 24 (= Acuity of 20/40 to 20/320) in the study eye were included; a higher score represents better functioning.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Who Gained at Least 10 Letters in BCVA as Measured by ETDRS Letter Score Compared With Baseline at Week 52 - LOCF</measure>
    <time_frame>Baseline and Week 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Who Gained at Least 15 Letters in BCVA as Measured by ETDRS Letter Score Compared With Baseline at Week 52 - LOCF</measure>
    <time_frame>Baseline and Week 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With a ≥2-step Improvement From Baseline in the ETDRS DRSS (Diabetic Retinopathy Severity Score) as Assessed by FP (Fundus Photography) at Week 52 - LOCF</measure>
    <time_frame>Baseline and Week 52</time_frame>
    <description>Baseline ETDRS DRSS: None (level 10); Mild to moderate nonproliferative DR (levels 14, 15, 20, 35, and 43); Moderately severe/severe nonproliferative DR (levels 47 and 53); Mild/moderate/high-risk/advanced proliferative DR (levels 61, 65, 71,75, 81, and 85)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Central Retinal Thickness (CRT) at Week 52 as Assessed on Optical Coherence Tomography (OCT) - LOCF</measure>
    <time_frame>Baseline and Week 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) Near Activities Subscale at Week 52 - LOCF</measure>
    <time_frame>Baseline and Week 52</time_frame>
    <description>The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales that are all scored from 0-100. Near activities are defined as reading ordinary print in newspapers, performing work or hobbies requiring near vision, or finding something on a crowded shelf.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) Distance Activities Subscale at Week 52 - LOCF</measure>
    <time_frame>Baseline and Week 52</time_frame>
    <description>The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales that are all scored from 0-100. Distance activities are defined as reading street signs or names on stores, and going down stairs, steps, or curbs.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">466</enrollment>
  <condition>Diabetic Macular Edema</condition>
  <arm_group>
    <arm_group_label>Macular Laser Photocoagulation Treatment (Control)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants received macular laser treatment at baseline and as-needed at visits at which laser re-treatment criteria were met, but no more frequently than every 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q8</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks for 5 visits followed by injections every 8 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321)</intervention_name>
    <arm_group_label>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q4</arm_group_label>
    <arm_group_label>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q8</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Macular Laser Photocoagulation</intervention_name>
    <description>Laser therapy</description>
    <arm_group_label>Macular Laser Photocoagulation Treatment (Control)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        The following is an abbreviated list of inclusion criteria:

          -  Adults ≥ 18 years with type 1 or 2 diabetes mellitus

          -  Decrease in vision determined to be primarily the result of DME in the study eye

          -  BCVA ETDRS letter score of 73 to 24 (20/40 to 20/320) in the study eye

        Exclusion Criteria:

        The following is an abbreviated list of exclusion criteria:

          -  Laser photocoagulation (panretinal or macular) in the study eye within 90 days of day
             1

          -  Previous use of intraocular or periocular corticosteroids in the study eye within 120
             days of day 1

          -  Previous treatment with anti-angiogenic drugs in the study eye (pegaptanib sodium,
             bevacizumab, ranibizumab, etc.) within 90 days of day 1

          -  Active proliferative diabetic retinopathy (PDR) in the study eye

          -  Uncontrolled diabetes mellitus

          -  Only 1 functional eye even if that eye is otherwise eligible for the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Trial Management</last_name>
    <role>Study Director</role>
    <affiliation>Regeneron Pharmaceuticals</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Arcadia</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mountain View</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Palm Desert</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Santa Barbara</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Golden</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New London</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fort Myers</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Winter Haven</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Aiea</city>
        <state>Hawaii</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Portland</city>
        <state>Maine</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Missoula</city>
        <state>Montana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Northfield</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Teaneck</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lynbrook</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orchard Park</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kingston</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Florence</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>West Columbia</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Abilene</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Harlingen</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Antonio (2 locations)</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>The Woodlands</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Canada</country>
    <country>India</country>
    <country>Israel</country>
  </removed_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 27, 2011</study_first_submitted>
  <study_first_submitted_qc>May 31, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 1, 2011</study_first_posted>
  <results_first_submitted>August 28, 2014</results_first_submitted>
  <results_first_submitted_qc>April 2, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 20, 2015</results_first_posted>
  <disposition_first_submitted>February 11, 2014</disposition_first_submitted>
  <disposition_first_submitted_qc>February 11, 2014</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">March 13, 2014</disposition_first_posted>
  <last_update_submitted>April 25, 2016</last_update_submitted>
  <last_update_submitted_qc>April 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetic Macular Edema</keyword>
  <keyword>Diabetic Retinopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Edema</mesh_term>
    <mesh_term>Macular Edema</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants with diabetic macular edema (DME) secondary to diabetes mellitus involving the center of the macula in the study eye could participate in the study.</recruitment_details>
      <pre_assignment_details>Of 687 participants who were screened for inclusion in the study, 466 were enrolled (started) and 461 received treatment.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Macular Laser Photocoagulation Treatment (Control)</title>
          <description>Participants received macular laser treatment at baseline and as-needed at visits at which laser re-treatment criteria were met, but no more frequently than every 12 weeks.</description>
        </group>
        <group group_id="P2">
          <title>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q4</title>
          <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks.</description>
        </group>
        <group group_id="P3">
          <title>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q8</title>
          <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks for 5 visits followed by injections every 8 weeks.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="156">randomized</participants>
                <participants group_id="P2" count="156">randomized</participants>
                <participants group_id="P3" count="154">randomized</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Participants Received Treatment</title>
              <participants_list>
                <participants group_id="P1" count="154">safety analysis set (SAF)</participants>
                <participants group_id="P2" count="155">safety analysis set (SAF)</participants>
                <participants group_id="P3" count="152">safety analysis set (SAF)</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Completed Week 52</title>
              <participants_list>
                <participants group_id="P1" count="145"/>
                <participants group_id="P2" count="146"/>
                <participants group_id="P3" count="144"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Completed Week 100</title>
              <participants_list>
                <participants group_id="P1" count="133"/>
                <participants group_id="P2" count="125"/>
                <participants group_id="P3" count="127"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="133">Completed Week 100</participants>
                <participants group_id="P2" count="125">Completed Week 100</participants>
                <participants group_id="P3" count="127">Completed Week 100</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="31"/>
                <participants group_id="P3" count="27"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Baseline population analyzed using the SAF</population>
      <group_list>
        <group group_id="B1">
          <title>Control</title>
          <description>Participants received macular laser treatment at baseline and as-needed at visits at which laser re-treatment criteria were met, but no more frequently than every 12 weeks.</description>
        </group>
        <group group_id="B2">
          <title>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q4</title>
          <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks.</description>
        </group>
        <group group_id="B3">
          <title>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q8</title>
          <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks for 5 visits followed by injections every 8 weeks.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="154"/>
            <count group_id="B2" value="155"/>
            <count group_id="B3" value="152"/>
            <count group_id="B4" value="461"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.7" spread="8.65"/>
                    <measurement group_id="B2" value="62" spread="11.16"/>
                    <measurement group_id="B3" value="63.1" spread="9.36"/>
                    <measurement group_id="B4" value="62.2" spread="9.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                    <measurement group_id="B2" value="68"/>
                    <measurement group_id="B3" value="73"/>
                    <measurement group_id="B4" value="210"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="85"/>
                    <measurement group_id="B2" value="87"/>
                    <measurement group_id="B3" value="79"/>
                    <measurement group_id="B4" value="251"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Best Corrected Visual Acuity (BCVA) as Measured by Early Treatment Diabetic Retinopathy Study (ETDRS) Letter Score at Week 52 - Last Observation Carried Forward (LOCF)</title>
        <description>Visual function of the study eye was assessed using the ETDRS protocol. Participants with a BCVA ETDRS letter score of 73 to 24 (= Acuity of 20/40 to 20/320) in the study eye were included; a higher score represents better functioning.</description>
        <time_frame>Baseline and Week 52</time_frame>
        <population>The Primary efficacy endpoint was analyzed using the full analysis set (FAS). The FAS included all 'Participants received Treatment' and had a baseline and at least 1 post-baseline assessment of Best Corrected Visual Acuity (BCVA).</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Participants received macular laser treatment at baseline and as-needed at visits at which laser re-treatment criteria were met, but no more frequently than every 12 weeks.</description>
          </group>
          <group group_id="O2">
            <title>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q4</title>
            <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks.</description>
          </group>
          <group group_id="O3">
            <title>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q8</title>
            <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks for 5 visits followed by injections every 8 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Best Corrected Visual Acuity (BCVA) as Measured by Early Treatment Diabetic Retinopathy Study (ETDRS) Letter Score at Week 52 - Last Observation Carried Forward (LOCF)</title>
          <description>Visual function of the study eye was assessed using the ETDRS protocol. Participants with a BCVA ETDRS letter score of 73 to 24 (= Acuity of 20/40 to 20/320) in the study eye were included; a higher score represents better functioning.</description>
          <population>The Primary efficacy endpoint was analyzed using the full analysis set (FAS). The FAS included all 'Participants received Treatment' and had a baseline and at least 1 post-baseline assessment of Best Corrected Visual Acuity (BCVA).</population>
          <units>letters correctly read</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="154"/>
                <count group_id="O2" value="154"/>
                <count group_id="O3" value="151"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".10" spread="1.03"/>
                    <measurement group_id="O2" value="12.3" spread=".76"/>
                    <measurement group_id="O3" value="10.6" spread=".69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>12.19</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>9.35</ci_lower_limit>
            <ci_upper_limit>15.04</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>10.45</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>7.73</ci_lower_limit>
            <ci_upper_limit>13.17</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Who Gained at Least 10 Letters in BCVA as Measured by ETDRS Letter Score Compared With Baseline at Week 52 - LOCF</title>
        <time_frame>Baseline and Week 52</time_frame>
        <population>All secondary efficacy endpoints were analyzed using the full analysis set (FAS). The FAS included all 'Participants received Treatment' and had a baseline and at least 1 post-baseline assessment of Best Corrected Visual Acuity (BCVA).</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Participants received macular laser treatment at baseline and as-needed at visits at which laser re-treatment criteria were met, but no more frequently than every 12 weeks.</description>
          </group>
          <group group_id="O2">
            <title>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q4</title>
            <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks.</description>
          </group>
          <group group_id="O3">
            <title>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q8</title>
            <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks for 5 visits followed by injections every 8 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Who Gained at Least 10 Letters in BCVA as Measured by ETDRS Letter Score Compared With Baseline at Week 52 - LOCF</title>
          <population>All secondary efficacy endpoints were analyzed using the full analysis set (FAS). The FAS included all 'Participants received Treatment' and had a baseline and at least 1 post-baseline assessment of Best Corrected Visual Acuity (BCVA).</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="154"/>
                <count group_id="O2" value="154"/>
                <count group_id="O3" value="151"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="100"/>
                    <measurement group_id="O3" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.0001</p_value>
            <method>Cochran-Mantel-Haenszel</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>45.9</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>34.7</ci_lower_limit>
            <ci_upper_limit>57.0</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.0001</p_value>
            <method>Cochran-Mantel-Haenszel</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>38.8</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>27.2</ci_lower_limit>
            <ci_upper_limit>50.3</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Who Gained at Least 15 Letters in BCVA as Measured by ETDRS Letter Score Compared With Baseline at Week 52 - LOCF</title>
        <time_frame>Baseline and Week 52</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Participants received macular laser treatment at baseline and as-needed at visits at which laser re-treatment criteria were met, but no more frequently than every 12 weeks.</description>
          </group>
          <group group_id="O2">
            <title>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q4</title>
            <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks.</description>
          </group>
          <group group_id="O3">
            <title>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q8</title>
            <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks for 5 visits followed by injections every 8 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Who Gained at Least 15 Letters in BCVA as Measured by ETDRS Letter Score Compared With Baseline at Week 52 - LOCF</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="154"/>
                <count group_id="O2" value="154"/>
                <count group_id="O3" value="151"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="64"/>
                    <measurement group_id="O3" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Cochran-Mantel-Haenszel</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>34.2</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>24.1</ci_lower_limit>
            <ci_upper_limit>44.4</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <method>Cochran-Mantel-Haenszel</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>23.3</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>13.5</ci_lower_limit>
            <ci_upper_limit>33.1</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With a ≥2-step Improvement From Baseline in the ETDRS DRSS (Diabetic Retinopathy Severity Score) as Assessed by FP (Fundus Photography) at Week 52 - LOCF</title>
        <description>Baseline ETDRS DRSS: None (level 10); Mild to moderate nonproliferative DR (levels 14, 15, 20, 35, and 43); Moderately severe/severe nonproliferative DR (levels 47 and 53); Mild/moderate/high-risk/advanced proliferative DR (levels 61, 65, 71,75, 81, and 85)</description>
        <time_frame>Baseline and Week 52</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Participants received macular laser treatment at baseline and as-needed at visits at which laser re-treatment criteria were met, but no more frequently than every 12 weeks.</description>
          </group>
          <group group_id="O2">
            <title>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q4</title>
            <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks.</description>
          </group>
          <group group_id="O3">
            <title>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q8</title>
            <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks for 5 visits followed by injections every 8 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With a ≥2-step Improvement From Baseline in the ETDRS DRSS (Diabetic Retinopathy Severity Score) as Assessed by FP (Fundus Photography) at Week 52 - LOCF</title>
          <description>Baseline ETDRS DRSS: None (level 10); Mild to moderate nonproliferative DR (levels 14, 15, 20, 35, and 43); Moderately severe/severe nonproliferative DR (levels 47 and 53); Mild/moderate/high-risk/advanced proliferative DR (levels 61, 65, 71,75, 81, and 85)</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="154"/>
                <count group_id="O2" value="154"/>
                <count group_id="O3" value="151"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="52"/>
                    <measurement group_id="O3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <method>Cochran-Mantel-Haenszel</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>19.7</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>9.0</ci_lower_limit>
            <ci_upper_limit>30.4</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0017</p_value>
            <method>Cochran-Mantel-Haenszel</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>14.9</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>4.4</ci_lower_limit>
            <ci_upper_limit>25.4</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Central Retinal Thickness (CRT) at Week 52 as Assessed on Optical Coherence Tomography (OCT) - LOCF</title>
        <time_frame>Baseline and Week 52</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Participants received macular laser treatment at baseline and as-needed at visits at which laser re-treatment criteria were met, but no more frequently than every 12 weeks.</description>
          </group>
          <group group_id="O2">
            <title>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q4</title>
            <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks.</description>
          </group>
          <group group_id="O3">
            <title>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q8</title>
            <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks for 5 visits followed by injections every 8 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Central Retinal Thickness (CRT) at Week 52 as Assessed on Optical Coherence Tomography (OCT) - LOCF</title>
          <units>microns</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="154"/>
                <count group_id="O2" value="154"/>
                <count group_id="O3" value="151"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-73.3" spread="12.09"/>
                    <measurement group_id="O2" value="-184.1" spread="6.57"/>
                    <measurement group_id="O3" value="-186.8" spread="6.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-110.8</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-141.3</ci_lower_limit>
            <ci_upper_limit>-80.22</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-113.5</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-144.2</ci_lower_limit>
            <ci_upper_limit>-82.75</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) Near Activities Subscale at Week 52 - LOCF</title>
        <description>The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales that are all scored from 0-100. Near activities are defined as reading ordinary print in newspapers, performing work or hobbies requiring near vision, or finding something on a crowded shelf.</description>
        <time_frame>Baseline and Week 52</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Participants received macular laser treatment at baseline and as-needed at visits at which laser re-treatment criteria were met, but no more frequently than every 12 weeks.</description>
          </group>
          <group group_id="O2">
            <title>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q4</title>
            <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks.</description>
          </group>
          <group group_id="O3">
            <title>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q8</title>
            <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks for 5 visits followed by injections every 8 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) Near Activities Subscale at Week 52 - LOCF</title>
          <description>The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales that are all scored from 0-100. Near activities are defined as reading ordinary print in newspapers, performing work or hobbies requiring near vision, or finding something on a crowded shelf.</description>
          <units>scores on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="154"/>
                <count group_id="O2" value="154"/>
                <count group_id="O3" value="151"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" spread="1.55"/>
                    <measurement group_id="O2" value="8.9" spread="1.58"/>
                    <measurement group_id="O3" value="8.1" spread="1.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0168</p_value>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>5.19</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_lower_limit>0.33</ci_lower_limit>
            <ci_upper_limit>10.04</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0323</p_value>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>4.36</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.21</ci_lower_limit>
            <ci_upper_limit>8.93</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) Distance Activities Subscale at Week 52 - LOCF</title>
        <description>The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales that are all scored from 0-100. Distance activities are defined as reading street signs or names on stores, and going down stairs, steps, or curbs.</description>
        <time_frame>Baseline and Week 52</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Participants received macular laser treatment at baseline and as-needed at visits at which laser re-treatment criteria were met, but no more frequently than every 12 weeks.</description>
          </group>
          <group group_id="O2">
            <title>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q4</title>
            <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks.</description>
          </group>
          <group group_id="O3">
            <title>Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) 2Q8</title>
            <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks for 5 visits followed by injections every 8 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) Distance Activities Subscale at Week 52 - LOCF</title>
          <description>The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales that are all scored from 0-100. Distance activities are defined as reading street signs or names on stores, and going down stairs, steps, or curbs.</description>
          <units>scores on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="154"/>
                <count group_id="O2" value="154"/>
                <count group_id="O3" value="151"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9" spread="1.44"/>
                    <measurement group_id="O2" value="7.7" spread="1.57"/>
                    <measurement group_id="O3" value="6.5" spread="1.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.1702</p_value>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>2.86</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.82</ci_lower_limit>
            <ci_upper_limit>7.54</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.4067</p_value>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>1.65</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.83</ci_lower_limit>
            <ci_upper_limit>6.13</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From the first study drug injection until 30 days after the last study drug injection at the latest from week 0 to week 100; From the first study drug injection until 30 days after the last study drug injection at the latest from week 0 to week 148.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Control (Week 0 to Week 100)</title>
          <description>Participants received macular laser treatment at baseline and as-needed at visits at which laser re-treatment criteria were met, but no more frequently than every 12 weeks.</description>
        </group>
        <group group_id="E2">
          <title>IAI;EYLEA®;BAY86-5321 2Q4 (Week 0 to Week 100)</title>
          <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks.</description>
        </group>
        <group group_id="E3">
          <title>IAI;EYLEA®;BAY86-5321) 2Q8 (Week 0 to Week 100)</title>
          <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks for 5 visits followed by injections every 8 weeks.</description>
        </group>
        <group group_id="E4">
          <title>Control (Week 0 to Week 148)</title>
          <description>Participants received macular laser treatment at baseline and as-needed at visits at which laser re-treatment criteria were met, but no more frequently than every 12 weeks.</description>
        </group>
        <group group_id="E5">
          <title>IAI;EYLEA®;BAY86-5321 2Q4 (Week 0 to Week 148)</title>
          <description>Participants received 2mg Intravitreal aflibercept injection(IAI) every 4 weeks.</description>
        </group>
        <group group_id="E6">
          <title>IAI;EYLEA®;BAY86-5321) 2Q8 (Week 0 to Week 148)</title>
          <description>Participants received 2mg Intravitreal aflibercept injection (IAI) every 4 weeks for 5 visits followed by injections every 8 weeks.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 16.1</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="67" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="67" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="56" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="84" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="85" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="75" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Haemorrhagic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Microcytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Nephrogenic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Normochromic normocytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis coronary artery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardiac failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="11" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cor pulmonale chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Coronary artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Coronary ostial stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Right ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Systolic dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cataract subcapsular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cataract subcapsular</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Corneal epithelium defect</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diabetic retinal oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diabetic retinal oedema</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diabetic retinopathy</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diabetic retinopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hyphaema</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Intraocular pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Iris neovascularisation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Lens dislocation</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Macular ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Punctate keratitis</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Punctate keratitis</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal artery occlusion</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal ischaemia</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal ischaemia</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal neovascularisation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal tear</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal vascular disorder</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal vein occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Visual acuity reduced</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Visual acuity reduced</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Vitreous opacities</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diabetic gastroparesis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Impaired gastric emptying</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Internal hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Mallory-Weiss syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Oesophageal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Volvulus of small bowel</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Device failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Device malfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Drug withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Generalised oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Medical device complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Systemic inflammatory response syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cholecystitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gallbladder cholesterolosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Appendicitis perforated</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Breast cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Burn infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Chronic sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Clostridium difficile infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diabetic foot infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Endocarditis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Endophthalmitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Endophthalmitis</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Enterococcal bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Escherichia urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Infected skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Klebsiella sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Mastoiditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Osteomyelitis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Parotitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Perineal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Staphylococcal bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Wound sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accident</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula site complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Arteriovenous graft site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cataract operation complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cataract traumatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Clavical fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Craniocerebral injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Seroma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Thoracic vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Ulna fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Wound haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Haematocrit decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Heart rate increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Intraocular pressure increased</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Transaminases increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Troponin increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Visual acuity tests abnormal</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diabetes with hyperosmolarity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Failure to thrive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Fluid retention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Ketosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cervical spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Joint effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Neuropathic arthropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Tendon disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Tendonitits</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Adenocarcinoma gastric</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Bladder cancer stage II</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Breast cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Chronic myeloid leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Chronic myelomonocytic leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Clear cell renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diffuse large B-cell lymphoma stage III</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Invasive ductal breast carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Melanocytic naevus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Prostate cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Rectal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Rectal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Renal cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Amnesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Autonomic nervous system imbalance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Brain injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Brain stem stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cognitive disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Coma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diabetic coma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hemianopia homonymous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypertensive encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Ischaemic cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Lacunar infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Metabolic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Multiple sclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Normal pressure hydrocephalus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Sedation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Thalamic infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Toxic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>VIIth nerve paralysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Visual field defect</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Affective disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Disorientation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Schizoaffective disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Azotaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Bladder outlet obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Calculus ureteric</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Intercapillary glomerulosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Nephropathy toxic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Nephrosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Nephrotic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Renal tubular necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Ureteric stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Breast mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Endometrial hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Labia enlarged</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Postmenopausal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Uterine mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypertrophic scar</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Arteriovenous fistula operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Coronary artery bypass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Foot amputation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypertensive emergency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypovolaemic shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Intermittent claudication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Malignant hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Peripheral artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 16.1</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="91" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="90" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="76" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="134" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="137" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="136" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="27" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="20" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="25" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="22" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="17" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="24" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="28" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="21" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cataract cortical</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cataract cortical</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cataract nuclear</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cataract nuclear</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cataract subcapsular</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="10" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cataract subcapsular</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="12" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="10" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Conjunctival haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="27" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="31" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="35" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="29" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Conjunctival haemorrhage</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="53" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="63" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="48" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="55" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="63" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="50" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Corneal abrasion</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diabetic retinal oedema</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="26" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="29" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="23" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diabetic retinopathy</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="16" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="18" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dry eye</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="13" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dry eye</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="16" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Eye irritation</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="14" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="15" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="13" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Eye irritation</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Eye pain</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="23" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="23" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="26" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Eye pain</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="13" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="14" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Foreign body sensation in eyes</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Lacrimation increased</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Lacrimation increased</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Macular fibrosis</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="20" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="13" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="17" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Macular fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="19" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="14" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="23" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Macular oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Ocular hyperaemia</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="12" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Photopsia</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Posterior capsule opacification</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="10" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Posterior capsule opacification</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="16" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="15" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Punctate keratitis</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal exudates</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="14" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="15" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal exudates</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="15" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="16" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="13" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="16" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal neovascularisation</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal neovascularisation</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal pigment epitheliopathy</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="14" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="11" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Visual Impairment</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Visual acuity reduced</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="10" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Visual acuity reduced</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="14" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="12" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Vitreous detachment</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="23" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="17" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="23" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Vitreous detachment</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="20" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="20" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="25" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Vitreous floaters</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="15" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="14" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Vitreous floaters</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="16" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="23" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="21" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="19" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="11" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="14" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="15" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="19" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="14" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="13" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="10" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="16" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="21" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="16" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="16" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="19" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="16" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Seasonal allergy</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="12" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="12" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="22" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="11" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="23" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="22" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="24" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="18" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="14" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="13" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="16" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="13" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="17" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="26" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="20" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="30" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="32" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="14" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="15" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="16" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="12" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Blood pressure systolic increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Glycosylated haemoglobin increased</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="16" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Intraocular pressure increased</sub_title>
                <description>Study eye</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="16" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="10" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Urine protein/ creatinine ratio increased</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="28" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="23" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="25" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypercholesterolaemia</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="11" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="14" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="12" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Vitamin D deficiency</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="13" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="12" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="22" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="12" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="10" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="22" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="21" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="13" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="13" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="16" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="21" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="20" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="15" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="13" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="49" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="41" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="42" subjects_at_risk="152"/>
                <counts group_id="E4" subjects_affected="56" subjects_at_risk="154"/>
                <counts group_id="E5" subjects_affected="51" subjects_at_risk="155"/>
                <counts group_id="E6" subjects_affected="49" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Not less than 45 days prior to submission of any (M)anuscript, (I)nstitution shall, or cause PI to, provide (S)ponsor a copy of (M). (I) to consider comments submitted by (S), &amp; to delete confidential information upon (S) request. At (S)'s request, (I) to delay publication for an additional 60 days to allow filing of patent applications. (I) &amp; PI agree to delay publication, prior to (M) summarizing data from all sites, unless no (M) is published prior to first anniversary of final study report.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Trial Management</name_or_title>
      <organization>Regeneron</organization>
      <phone>914 847 7000</phone>
      <email>clinicaltrials@regeneron.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

